Literature DB >> 8364010

Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells.

V N Bochkov1, V A Tkachuk, A W Hahn, J Bernhardt, F R Buhler, T J Resink.   

Abstract

Low-density (LDL) and high-density (HDL3) lipoproteins dose-dependently activate phosphoinositide turnover and elevate cytosolic free Ca2+ concentrations ([Ca2+]i) in cultured vascular smooth muscle cells (VSMCs) from either human (microarterioles and aorta) or rat (aorta) sources. High-performance liquid chromatography analysis of cell extracts revealed comparable spectra of inositol phosphate isomers generated in response to either LDL, HDL3, or angiotensin II (Ang II). Thus, lipoproteins and Ang II may use similar, if not identical, signal transduction pathways for the generation and metabolism of inositol phosphates and intracellular Ca2+ mobilization in VSMCs. When Ang II was added in combination with either LDL or HDL3, the phosphoinositide and [Ca2+]i responses of VSMCs were either equal to or even greater than the sum of the effects elicited by the agonists individually. This additivity/synergy between Ang II and the lipoproteins was not accompanied by alteration in the half-maximally effective dose requirements of VSMCs for either Ang II (approximately 2 nmol/L, with or without lipoproteins) or lipoproteins (approximately 50 micrograms/mL for LDL and HDL3, with or without Ang II). Neither short-term (up to 10 minutes) nor long-term (48 hours) exposure of VSMCs to lipoproteins caused desensitization of phospholipase C and intracellular Ca2+ mobilization responses to either Ang II or lipoproteins. Since constant exposure of VSMCs to lipoproteins is a physiological circumstance, and because elevation of [Ca2+]i and activation of phosphoinositide turnover are pivotal events for VSMC contraction and growth, we suggest that the low concentrations of lipoproteins in the vessel intima may play an important role in regulating the response of the vasculature to Ang II.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364010     DOI: 10.1161/01.atv.13.9.1261

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  6 in total

1.  Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor.

Authors:  T Herembert; J Gogusev; D L Zhu; T B Drueke; P Marche
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells.

Authors:  S Allen; S Khan; F Al-Mohanna; P Batten; M Yacoub
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

3.  Evidence that apoB-100 of low-density lipoproteins is a novel Src-related protein kinase.

Authors:  J Guevara; E T Walch; H F Epstein; J T Sparrow; A M Gotto; N V Valentinova
Journal:  J Protein Chem       Date:  1995-10

4.  Lipoproteins modulate expression of the macrophage scavenger receptor.

Authors:  J Han; A C Nicholson
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

5.  Regulation of the atheroma-enriched protein, SPRR3, in vascular smooth muscle cells through cyclic strain is dependent on integrin alpha1beta1/collagen interaction.

Authors:  Amy L Pyle; James B Atkinson; Ambra Pozzi; Jeff Reese; Beate Eckes; Jeffrey M Davidson; Dan L Crimmins; Pampee P Young
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

6.  Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.

Authors:  O Hernández-Perera; D Pérez-Sala; J Navarro-Antolín; R Sánchez-Pascuala; G Hernández; C Díaz; S Lamas
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.